Lord, Abbett & Co. LLC Surface Oncology, Inc. Transaction History

Lord, Abbett & Co. LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$3.65 - $10.69 $1.75 Million - $5.13 Million	-479,905 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$8.92 - $17.83 $120,482 - $240,829	13,507 Added 2.9%	479,905 $5.25 Million
Q2 2018 Aug 14, 2018	BUY	$12.83 - $17.41 $5.98 Million - $8.12 Million	466,398 New	466,398 $7.61 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.